- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
January 27, 2015 (FDA) - The U.S. Food and Drug Administration today allowed marketing of the first set of mobile medical apps that allow people with diabetes to automatically and securely share data from a continuous glucose monitor (CGM) with other people in real-time using an Apple mobile device such as an iPhone.
The Dexcom Share Direct Secondary Displays system's data-sharing capability allows caregivers to a person with diabetes to monitor that individual's blood sugar levels remotely throu
January 27, 2015 (Diabetes.co.uk) - A new study finds that incipient peripheral neuropathy in patients with type 1 diabetes can be predicted by a technique called corneal confocal microscopy (CCM).
What is corneal confocal microscopy?
CCM is a clinical technique that studies the structure and nerve fibres of the cornea, using a laser-scanning corneal confocal microscope.
CCM has previously been used to assess peripheral diabetic neur
Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults
January 22, 2015 (ACP) - Prolonged sedentary time was independently associated with deleterious health outcomes regardless of physical activity.
Read the study as seen in Annals of Internal Medicine here.
January 22, 2015 (HealthDayNews) - Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes patients, independent of weight loss, according to a study published in Diabetes Care.
Ali Ardestani, MD, from Brigham and Women's Hospital in Boston, and colleagues examined changes in insulin treatment after bariatric surgery in a cohort of 5,225 patients with insulin-treated type 2 diabetes. RYGB was compared w
January 22, 2015 (Healio) - In patients with type 2 diabetes, the addition of liraglutide to a metformin regimen appears to have a positive effect on oxidative stress, plasma ghrelin and heme oxygenase-1 levels, according to recent findings.
In the prospective pilot study, researchers evaluated 20 adults (10 men; mean age, 57 years) with type 2 diabetes who were assigned metformin